Genetics of hereditary pancreatic carcinoma

Clinics in Laboratory Medicine

Volumn 25, Issue 1, 2005, Pages 117-133

  Hahn, Stephan A ^a   Bartsch, Detlef K ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; ATM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE; PROTEIN CDKN2; PROTEIN KINASE LKB1; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P16; PROTEIN P53; PROTEIN PRSS1; PROTEINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ADENOMATOUS POLYP; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER CLASSIFICATION; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CARCINOMA; CYSTIC FIBROSIS; FAMILIAL CANCER; GENE MUTATION; GERM LINE; HEREDITY; HUMAN; MELANOMA; OVARY CANCER; PANCREAS CARCINOMA; PANCREATITIS; PEUTZ JEGHERS SYNDROME; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; REVIEW; SEGREGATION ANALYSIS; SYNDROME;

EID: 14644399736     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.12.008     Document Type: Review

References (84)

1. H.T. Lynch, R.M. Fusaro, W.J. Kimberling, J.F. Lynch, and B.S. Danes Familial atypical multiple mole-melanoma (FAMMM) syndrome: segregation analysis J Med Genet 20 5 1983 342 344
2. A.M. Goldstein, J.P. Struewing, A. Chidambaram, M.C. Fraser, and M.A. Tucker Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations J Natl Cancer Inst 92 12 2000 1006 1010
3. A. Borg, T. Sandberg, K. Nilsson, O. Johannsson, M. Klinker, and A. Masback High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families J Natl Cancer Inst 92 15 2000 1260 1266
4. H.F. Vasen, N.A. Gruis, R.R. Frants, P.A. van Der Velden, E.T. Hille, and W. Bergman Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden) Int J Cancer 87 6 2000 809 811
5. D.K. Bartsch, M. Sina-Frey, S. Lang, A. Wild, B. Gerdes, and P. Barth CDKN2A germline mutations in familial pancreatic cancer Ann Surg 236 6 2002 730 737
6. C.A. Moskaluk, H. Hruban, A. Lietman, T. Smyrk, L. Fusaro, and R. Fusaro Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas Hum Mutat 12 1 1998 70
7. P.S. Moore, G. Zamboni, M. Falconi, C. Bassi, and A. Scarpa A novel germline mutation, P48T, in the CDKN2A/p16 gene in a patient with pancreatic carcinoma Hum Mutat 16 5 2000 447 448
8. H.T. Lynch, R.E. Brand, D. Hogg, C.A. Deters, R.M. Fusaro, and J.F. Lynch Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome Cancer 94 1 2002 84 96
9. F.M. Giardiello, J.D. Brensinger, A.C. Tersmette, S.N. Goodman, G.M. Petersen, and S.V. Booker Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 6 2000 1447 1453
10. A. Hemminki, D. Markie, I. Tomlinson, E. Avizienyte, S. Roth, and A. Loukola A serine/threonine kinase gene defective in Peutz-Jeghers syndrome Nature 391 6663 1998 184 187
11. D.E. Jenne, H. Reimann, J. Nezu, W. Friedel, S. Loff, and R. Jeschke Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase Nat Genet 18 1 1998 38 43
12. W. Lim, N. Hearle, B. Shah, V. Murday, S.V. Hodgson, and A. Lucassen Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome Br J Cancer 89 2 2003 308 313
13. S.G. Martin, and D. St Johnston A role for drosophila LKB1 in anterior-posterior axis formation and epithelial polarity Nature 421 6921 2003 379 384
14. G.H. Su, R.H. Hruban, R.K. Bansal, G.S. Bova, D.J. Tang, and M.C. Shekher Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers Am J Pathol 154 6 1999 1835 1840
15. D.C. Whitcomb, M.C. Gorry, R.A. Preston, W. Furey, M.J. Sossenheimer, and C.D. Ulrich Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene Nat Genet 14 2 1996 141 145
16. B. Etemad, and D.C. Whitcomb Chronic pancreatitis: diagnosis, classification, and new genetic developments Gastroenterology 120 3 2001 682 707
17. J.A. Cohn, K.J. Friedman, P.G. Noone, M.R. Knowles, L.M. Silverman, and P.S. Jowell Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis N Engl J Med 339 10 1998 653 658
18. N. Sharer, M. Schwarz, G. Malone, A. Howarth, J. Painter, and M. Super Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis N Engl J Med 339 10 1998 645 652
19. H. Witt, W. Luck, H.C. Hennies, M. Classen, A. Kage, and U. Lass Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis Nat Genet 25 2 2000 213 216
20. M.P. Audrezet, J.M. Chen, C. Le Marechal, P. Ruszniewski, M. Robaszkiewicz, and O. Roguenes Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis Eur J Hum Genet 10 2 2002 100 106
21. A.B. Lowenfels, P. Maisonneuve, E.P. DiMagno, Y. Elitsur, L.J. Gates, and J. Perrault Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group J Natl Cancer Inst 89 6 1997 442 446
22. A.B. Lowenfels, P. Maisonneuve, D.C. Whitcomb, M.M. Lerch, and E.P. DiMagno Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis JAMA 286 2 2001 169 170
23. P. Peltomaki, and H.F. Vasen Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer Gastroenterology 113 4 1997 1146 1158
24. H.T. Lynch, G.J. Voorhees, S.J. Lanspa, P.S. McGreevy, and J.F. Lynch Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study Br J Cancer 52 2 1985 271 273
25. M. Aarnio, R. Sankila, E. Pukkala, R. Salovaara, and L.A. Aaltonen Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 2 1999 214 218
26. M. Goggins, G.J. Offerhaus, W. Hilgers, C.A. Griffin, M. Shekher, and D. Tang Pancreatic adenocarcinomas with DNA replication errors (RER +) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER + Am J Pathol 152 6 1998 1501 1507
27. H. Tulinius, G.H. Olafsdottir, H. Sigvaldason, L. Tryggvadottir, and K. Bjarnadottir Neoplastic diseases in families of breast cancer patients J Med Genet 31 8 1994 618 621
28. C.M. Phelan, J.M. Lancaster, P. Tonin, C. Gumbs, C. Cochran, and R. Carter Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families Nat Genet 13 1 1996 120 122
29. P. Tonin, P. Ghadirian, C. Phelan, G.M. Lenoir, H.T. Lynch, and F. Letendre A large multisite cancer family is linked to BRCA2 J Med Genet 32 12 1995 982 984
30. J. Simard, P. Tonin, F. Durocher, K. Morgan, J. Rommens, and S. Gingras Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families Nat Genet 8 4 1994 392 398
31. D. Thompson, and D.F. Easton Cancer Incidence in BRCA1 mutation carriers J Natl Cancer Inst 94 18 2002 1358 1365
32. H.A. Risch, J.R. McLaughlin, D.E. Cole, B. Rosen, L. Bradley, and E. Kwan Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer Am J Hum Genet 68 3 2001 700 710
33. G.J. Offerhaus, F.M. Giardiello, A.J. Krush, S.V. Booker, A.C. Tersmette, and N.C. Kelly The risk of upper gastrointestinal cancer in familial adenomatous polyposis Gastroenterology 102 6 1992 1980 1982
34. K. Yashima, S. Nakamori, Y. Murakami, A. Yamaguchi, K. Hayashi, and O. Ishikawa Mutations of the adenomatous polyposis coli gene in the mutation cluster region: comparison of human pancreatic and colorectal cancers Int J Cancer 59 1 1994 43 47
35. H.T. Lynch Genetics and pancreatic cancer Arch Surg 129 3 1994 266 268
36. F.J. Tedesco, R. Brown, and B.M. Schuman Pancreatic carcinoma in a patient with cystic fibrosis Gastrointest Endosc 32 1 1986 25 26
37. R.A. Schoumacher, J. Ram, M.C. Iannuzzi, N.A. Bradbury, R.W. Wallace, and C.T. Hon A cystic fibrosis pancreatic adenocarcinoma cell line Proc Natl Acad Sci U S A 87 10 1990 4012 4016
38. C.D. Sheldon, M.E. Hodson, L.M. Carpenter, and A.J. Swerdlow A cohort study of cystic fibrosis and malignancy Br J Cancer 68 5 1993 1025 1028
39. G.J. Tsongalis, G. Faber, F.G. Dalldorf, K.J. Friedman, L.M. Silverman, and J.R. Yankaskas Association of pancreatic adenocarcinoma, mild lung disease, and delta F508 mutation in a cystic fibrosis patient Clin Chem 40 10 1994 1972 1974
40. R. Pezzilli, A.M. Morselli-Labate, V. Mantovani, E. Romboli, P. Selva, and M. Migliori Mutations of the CFTR gene in pancreatic disease Pancreas 27 4 2003 332 336
41. R.H. Hruban, G.M. Petersen, P.K. Ha, and S.E. Kern Genetics of pancreatic cancer: from genes to families Surg Oncol Clin N Am 7 1 1998 1 23
42. R.H. Hruban, G.M. Petersen, M. Goggins, A.C. Tersmette, G.J. Offerhaus, and F. Falatko Familial pancreatic cancer Ann Oncol 10 Suppl 4 1999 69 73
43. D. Bartsch, M. Sina-Frey, A. Ziegler, S.A. Hahn, E. Przypadlo, and R. Kress Update of familial pancreatic cancer in Germany Pancreatology 1 2001 510 516
44. A.P. Klein, T.H. Beaty, J.E. Bailey-Wilson, K.A. Brune, R.H. Hruban, and G.M. Petersen Evidence for a major gene influencing risk of pancreatic cancer Genet Epidemiol 23 2 2002 133 149
45. M.A. Eberle, R. Pfutzer, K.L. Pogue-Geile, M.P. Bronner, D. Crispin, and M.B. Kimmey A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34 Am J Hum Genet 70 4 2002 1044 1048
46. H.T. Lynch, S.J. Lanspa, R.J. Fitzgibbons Jr., T. Smyrk, M.L. Fitzsimmons, and J. McClellan Familial pancreatic cancer (Part 1): Genetic pathology review Nebraska Medical Journal 74 5 1989 109 112
47. A.C. Tersmette, G.M. Petersen, G.J. Offerhaus, F.C. Falatko, K.A. Brune, and M. Goggins Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer Clin Cancer Res 7 3 2001 738 744
48. D.T. Silverman, M. Schiffman, J. Everhart, A. Goldstein, K.D. Lillemoe, and G.M. Swanson Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer Br J Cancer 80 11 1999 1830 1837
49. K. Hemminki, and X. Li Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden Int J Cancer 103 4 2003 525 530
50. D.K. Bartsch, R. Kress, M. Sina-Frey, R. Grützmann, B. Gerdes, and C. Pilarsky Prevalence of familial pancreatic cancer in Germany Int J Cancer 110 2004 902 960
51. D.T. Silverman, J.A. Dunn, R.N. Hoover, M. Schiffman, K.D. Lillemoe, and J.B. Schoenberg Cigarette smoking and pancreas cancer: a case-control study based on direct interviews J Natl Cancer Inst 86 20 1994 1510 1516
52. E.B. Gold, and S.B. Goldin Epidemiology of and risk factors for pancreatic cancer Surg Oncol Clin N Am 7 1 1998 67 91
53. S. Rulyak, A. Lowenfels, P. Maissoneuve, and T. Brentnall Smoking as a risk factor in familial pancreatic cancer kindreds Pancreatology 1 2001 551
54. S.A. Hahn, and W.H. Schmiegel Recent discoveries in cancer genetics of exocrine pancreatic neoplasia Digestion 59 5 1998 493 501
55. M. Schutte, L.T. da Costa, S.A. Hahn, C. Moskaluk, A.T.M.S. Hoque, and E. Rozenblum Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region Proc Natl Acad Sci U S A 92 1995 5950 5954
56. G.H. Su, W. Hilgers, M.C. Shekher, D.J. Tang, C.J. Yeo, and R.H. Hruban Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene Cancer Res 58 11 1998 2339 2342
57. G.H. Su, R. Bansal, K.M. Murphy, E. Montgomery, C.J. Yeo, and R.H. Hruban ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma Proc Natl Acad Sci U S A 98 6 2001 3254 3257
58. P.M. Hempen, L. Zhang, R.K. Bansal, C.A. Iacobuzio-Donahue, K.M. Murphy, and A. Maitra Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers Cancer Res 63 5 2003 994 999
59. E.S. Calhoun, J.B. Jones, R. Ashfaq, V. Adsay, S.J. Baker, and V. Valentine BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer. Potential therapeutic targets Am J Pathol 163 4 2003 1255 1260
60. K.M. Murphy, K.A. Brune, C. Griffin, J.E. Sollenberger, G.M. Petersen, and R. Bansal Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17% Cancer Res 62 13 2002 3789 3793
61. M. Goggins, M. Schutte, J. Lu, C.A. Moskaluk, C.L. Weinstein, and G.M. Peterson Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 1996 5360 5364
62. H. Ozcelik, B. Schmocker, N. Di Nicola, X.H. Shi, B. Langer, and M. Moore Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients Nat Genet 16 1 1997 17 18
63. C. Oddoux, J.P. Struewing, C.M. Clayton, S. Neuhausen, L.C. Brody, and M. Kaback The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% Nat Genet 14 2 1996 188 190
64. White K, Held KR. Weber BH A BRCA2 germ-line mutation in familial pancreatic carcinoma. Int J Cancer 2001;91(5):742-4.
65. S.A. Hahn, B. Greenhalf, I. Ellis, M. Sina-Frey, H. Rieder, and B. Korte BRCA2 germline mutations in familial pancreatic carcinoma J Natl Cancer Inst 95 3 2003 214 221
66. M. Goggins, R.H. Hruban, and S.E. Kern BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications Am J Pathol 156 5 2000 1767 1771
67. K.W. Kinzler, and B. Vogelstein Cancer-susceptibility genes. Gatekeepers and caretakers Nature 386 6627 1997 761 763
68. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2 2002 171 182
69. S.J. Rulyak, and T.A. Brentnall Inherited pancreatic cancer: Surveillance and treatment strategies for affected families Pancreatology 1 2001 477 486
70. R.H. Hruban, N.V. Adsay, J. Albores-Saavedra, C. Compton, E.S. Garrett, and S.N. Goodman Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions Am J Surg Pathol 25 5 2001 579 586
71. C.A. Moskaluk, R.H. Hruban, and S.E. Kern p16 and K-ras mutations in the intraductal precursors of human pancreatic adenocarcinoma Cancer Res 57 1997 2140 2143
72. E. Heinmöller, W. Dietmaier, H. Zirngibl, P. Heinmöller, W. Scaringe, and K.W. Jauch Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma Am J Pathol 157 1 2000 83 92
73. M. Yamano, H. Fujii, T. Takagaki, N. Kadowaki, H. Watanabe, and T. Shirai Genetic progression and divergence in pancreatic carcinoma Am J Pathol 156 6 2000 2123 2133
74. J. Lüttges, H. Galehdari, V. Bröcker, I. Schwarte-Waldhoff, D. Henne-Bruns, and G. Klöppel Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis Am J Pathol 158 2001 1677 1683
75. J.D. Day, J.A. Digiuseppe, C. Yeo, M. Lai-Goldman, S.M. Anderson, and S.N. Goodman Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms Hum Pathol 27 2 1996 119 124
76. A. Maitra, C. Iacobuzio-Donahue, A. Rahman, T.A. Sohn, P. Argani, and R. Meyer Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47 Am J Clin Pathol 118 1 2002 52 59
77. S.P. Thayer, M.P. Di Magliano, P.W. Heiser, C.M. Nielsen, D.J. Roberts, and G.Y. Lauwers Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis Nature 425 6960 2003 851 856
78. H.U. Park, J.W. Kim, G.E. Kim, H.I. Bae, S.C. Crawley, and S.C. Yang Aberrant Expression of MUC3 and MUC4 membrane-associated mucins and sialyl lex antigen in pancreatic intraepithelial neoplasia Pancreas 26 3 2003 E48 E54
79. A. Maitra, N.V. Adsay, P. Argani, C. Iacobuzio-Donahue, A. De Marzo, and J.L. Cameron Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray Mod Pathol 16 9 2003 902 912
80. N.T. van Heek, A.K. Meeker, S.E. Kern, C.J. Yeo, K.D. Lillemoe, and J.L. Cameron Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia Am J Pathol 161 5 2002 1541 1547
81. M.J. Swartz, S.K. Batra, G.C. Varshney, M.A. Hollingsworth, C.J. Yeo, and J.L. Cameron MUC4 expression increases progressively in pancreatic intraepithelial neoplasia Am J Clin Pathol 117 5 2002 791 796
82. A. Maitra, R. Ashfaq, C.R. Gunn, A. Rahman, C.J. Yeo, and T.A. Sohn Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging Am J Clin Pathol 118 2 2002 194 201
83. N. Fukushima, N. Sato, T. Ueki, C. Rosty, K.M. Walter, and R.E. Wilentz Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma Am J Pathol 160 5 2002 1573 1581
84. A.V. Biankin, J.G. Kench, A.L. Morey, C.S. Lee, S.A. Biankin, and D.R. Head Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia Cancer Res 61 24 2001 8830 8837